Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 6
2015 10
2016 19
2017 16
2018 23
2019 15
2020 4
2021 4
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-mediated protection against Ebola virus.
Saphire EO, Schendel SL, Gunn BM, Milligan JC, Alter G. Saphire EO, et al. Nat Immunol. 2018 Nov;19(11):1169-1178. doi: 10.1038/s41590-018-0233-9. Epub 2018 Oct 17. Nat Immunol. 2018. PMID: 30333617 Free PMC article. Review.
Animal models for filovirus infections.
Siragam V, Wong G, Qiu XG. Siragam V, et al. Zool Res. 2018 Jan 18;39(1):15-24. doi: 10.24272/j.issn.2095-8137.2017.053. Zool Res. 2018. PMID: 29511141 Free PMC article. Review.
Antibody therapeutics for Ebola virus disease.
Zeitlin L, Whaley KJ, Olinger GG, Jacobs M, Gopal R, Qiu X, Kobinger GP. Zeitlin L, et al. Curr Opin Virol. 2016 Apr;17:45-49. doi: 10.1016/j.coviro.2016.01.006. Epub 2016 Jan 27. Curr Opin Virol. 2016. PMID: 26826442 Free PMC article. Review.
Bispecific antibodies for viral immunotherapy.
Nyakatura EK, Soare AY, Lai JR. Nyakatura EK, et al. Hum Vaccin Immunother. 2017 Apr 3;13(4):836-842. doi: 10.1080/21645515.2016.1251536. Epub 2016 Oct 27. Hum Vaccin Immunother. 2017. PMID: 27786606 Free PMC article. Review.
Achieving cross-reactivity with pan-ebolavirus antibodies.
King LB, Milligan JC, West BR, Schendel SL, Ollmann Saphire E. King LB, et al. Curr Opin Virol. 2019 Feb;34:140-148. doi: 10.1016/j.coviro.2019.01.003. Epub 2019 Mar 15. Curr Opin Virol. 2019. PMID: 30884329 Free PMC article. Review.
Lassa virus glycoprotein: stopping a moving target.
Hastie KM, Saphire EO. Hastie KM, et al. Curr Opin Virol. 2018 Aug;31:52-58. doi: 10.1016/j.coviro.2018.05.002. Epub 2018 May 26. Curr Opin Virol. 2018. PMID: 29843991 Free PMC article. Review.
Antibody therapy for Lassa fever.
Cross RW, Hastie KM, Mire CE, Robinson JE, Geisbert TW, Branco LM, Ollmann Saphire E, Garry RF. Cross RW, et al. Curr Opin Virol. 2019 Aug;37:97-104. doi: 10.1016/j.coviro.2019.07.003. Epub 2019 Aug 8. Curr Opin Virol. 2019. PMID: 31401518 Review.
Clinical Evaluation of Ebola Virus Disease Therapeutics.
Liu G, Wong G, Su S, Bi Y, Plummer F, Gao GF, Kobinger G, Qiu X. Liu G, et al. Trends Mol Med. 2017 Sep;23(9):820-830. doi: 10.1016/j.molmed.2017.07.002. Epub 2017 Aug 17. Trends Mol Med. 2017. PMID: 28822631 Free PMC article. Review.
Funding vaccines for emerging infectious diseases.
Wong G, Qiu X. Wong G, et al. Hum Vaccin Immunother. 2018 Jul 3;14(7):1760-1762. doi: 10.1080/21645515.2017.1412024. Epub 2018 Jan 16. Hum Vaccin Immunother. 2018. PMID: 29194012 Free PMC article.
95 results